Hybrid Treatment Planning in Breast and Esophageal Cancer: A Feasible Approach for High-Volume Radiotherapy Centers

Key Points

• This research explores the feasibility of hybrid treatment planning for breast and esophageal cancer in high-volume radiotherapy centers.
• Comparison of hybrid planning to IMRT in terms of planning time and organ at risk (OAR) doses.
• Assessment of patient outcomes in high-patient-volume settings.
• Hybrid planning shows comparable planning time to IMRT.
• Hybrid planning provides reduced OAR doses compared to traditional methods.